Pancrelipase Lipase, Pancrelipase Amylase, and Pancrelipase Protease
PANCREAZE
NADAC/unit
N/A
No Shortage
PA Req: 1.8%
Market Intelligence
2023-07-19 Class III Recall: Vivus, Inc.
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.